Latest stories on AMRX
Amneal Pharmaceuticals Q2 2026 Earnings Preview
Seeking Alpha56 · neutralearnings
Amneal: Kashiv Deal Fuels Biosimilar Growth, But Stock Already Prices In Optimism
Seeking Alpha53 · neutralgeneral
Amneal Expands Iohexol Injection Portfolio with U.S. FDA Approval of Additional Strengths and Presentations
Business Insider63 · neutralproduct/pr
Amneal to Report Second Quarter 2026 Results on July 30, 2026
Business Insider50 · neutralgeneral
Amneal to Report Second Quarter 2026 Results on July 30, 2026 | AMRX Stock News
StockTitan50 · neutralearnings
Alkermes Ends Generic VIVITROL Supply Agreement with Amneal
TipRanks48 · neutralgeneral
Dispensary of Hope Launches "Hope Alliance" Campaign with Support from Amneal Pharmaceuticals | AMRX Stock News
StockTitan63 · neutralproduct/pr
Amneal Pharmaceuticals Bets on Biosimilars, Patches to Power Next Growth Phase
Yahoo Top63 · neutralproduct/pr
Amneal Pharmaceuticals, Inc. (AMRX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Seeking Alpha55 · neutralgeneral
Amneal Announces U.S. FDA Approval of Romidepsin Injection Solution | AMRX Stock News
StockTitan62 · neutralproduct/pr
Amneal to Participate in Goldman Sachs 47th Annual Global Healthcare Conference 2026 | AMRX Stock News
StockTitan55 · neutralgeneral
Amneal Pharma Bets Big on Biosimilars in Q1 Call
TipRanks63 · neutralearnings